跳至主要内容
临床试验/ISRCTN27483786
ISRCTN27483786进行中(未招募)未知

Minimally invasive versus open pancreatoduodenectomy for pancreatic and periampullary neoplasms (DIPLOMA-2): an international multicenter patient-blinded randomized controlled trial

Amsterdam University Medical Centers0 个研究点目标入组 288 人开始时间: 2022年1月11日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
288

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37828593/ (added 16/10/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age at least 18 years
  • 2. Indication for elective pancreatoduodenectomy for a tumor located in the pancreatic head, distal bile duct, duodenum or ampulla of Vater
  • 3. Both minimally invasive pancreatoduodenectomy and open pancreatoduodenectomy are technically feasible for radical resection, according to the local treatment team
  • 4. Pre-operative multiphase CT scan showing no signs of vascular involvement (in case of (suspected) malignancy: maximum 28 days old CT-scan available)
  • 5. Fit to undergo pancreatoduodenectomy according to the surgeon and anesthesiologist
  • 6. Written informed consent

排除标准

  • 1. A second cancer requiring resection during the same procedure
  • 2. Chronic pancreatitis as indication (including Groove pancreatitis)
  • 3. Any vascular involvement (portal vein, superior mesenteric vein, superior mesenteric artery, coeliac artery or hepatic artery)
  • 4. Pregnancy
  • 5. Body mass index >35 kg/m²
  • 6. Participation in another study with interference of study outcomes

研究者

发起方
Amsterdam University Medical Centers

相似试验